Search images on Google      Product Monograph

Active Ingredients:

• fludeoxyglucose 18f, 232 GBQ/VIAL

DIN: 02462354

Dosage Form(s): SOLUTION

Route(s) of Administration: INTRAVENOUS

Description: >0.5 GBQ

Schedule: Schedule C

Company: LAWSON HEALTH RESEARCH INSTITUTE

ATC:

• V09 - DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, WHO, Wiki)
• V09I - TUMOUR DETECTION (ATC, WHO)
• V09IX - Other diagnostic radiopharmaceuticals for tumour detection (ATC, WHO)
• V09IX04 - FLUDEOXYGLUCOSE (18F) (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: 20ML

 

External Links for Fludeoxyglucose (F-18):

Search on Google

• Fludeoxyglucose (F-18) side effects
• Fludeoxyglucose (F-18) dosage
• fludeoxyglucose 18f side effects
• fludeoxyglucose 18f dosage